ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

VSI Vitamin Shoppe Inc

6.50
0.00 (0.00%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Vitamin Shoppe Inc NYSE:VSI NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.50 0 01:00:00

Current Report Filing (8-k)

06/06/2019 9:36pm

Edgar (US Regulatory)


 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) June 6, 2019

 

 

VITAMIN SHOPPE, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-34507   11-3664322
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

300 Harmon Meadow Blvd.

Secaucus, New Jersey 07094

(Address of Principal Executive Offices, including Zip Code)

(201) 868-5959

(Registrant’s Telephone Number, including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading Symbol(s)

 

Name of each exchange
on which registered

Common Stock, $0.01 par value per share   VSI   The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


ITEM 5.07

Submission of Matters to a Vote of Security Holders.

 

  (a)

The Annual Meeting of Vitamin Shoppe, Inc. (the “Company”) was held on June 5, 2019 (the “Annual Meeting”).

 

  (b)

The final voting results for each of the matters submitted to a vote of the stockholders of the Company at the Annual Meeting were as follows:

Proposal 1 – Election of Directors.

The final results of the voting for nine (9) Directors for an annual term are set forth below:

 

     FOR      AGAINST      ABSTAIN      NON-VOTES  

Deborah M. Derby

     15,891,370        380,741        11,366        5,249,367  

David H. Edwab

     15,695,254        576,825        11,398        5,249,367  

Melvin L. Keating

     15,913,338        364,215        5,924        5,249,367  

Sharon M. Leite

     15,879,124        388,163        16,190        5,249,367  

Guillermo G. Marmol

     15,884,494        387,605        11,378        5,249,367  

Himanshu H. Shah

     16,142,172        129,909        11,396        5,249,367  

Alexander W. Smith

     15,832,998        439,279        11,200        5,249,367  

Timothy J. Theriault

     15,868,187        403,882        11,408        5,249,367  

Sing Wang

     15,688,582        583,222        11,673        5,249,367  

Proposal 2 – Advisory and Non-Binding Vote to Approve Named Executive Officer Compensation.

The Company’s stockholders approved, on an advisory, non-binding basis, the compensation of our named executive officers based upon the following votes:

 

For

 

Against

 

Abstain

 

Non-Votes

15,481,044   490,797   311,636   5,249,367

Proposal 3 – Vote to Ratify the Appointment of Deloitte & Touche LLP as the Company’s Independent Registered Public Accounting Firm for the 2019 Fiscal Year.

The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the 2019 fiscal year based upon the following votes:

 

For

 

Against

 

Abstain

 

Non-Votes

21,083,230   442,462   7,152   0


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    VITAMIN SHOPPE, INC.
Date: June 6, 2019     By:   /s/ David M. Kastin
      Name:   David M. Kastin
      Title:   Senior Vice President, General Counsel and Corporate Secretary

1 Year Vitamin Shoppe Chart

1 Year Vitamin Shoppe Chart

1 Month Vitamin Shoppe Chart

1 Month Vitamin Shoppe Chart

Your Recent History

Delayed Upgrade Clock